Skip to content

Fortilink-TS IBF System with TETRAfuse 3D Technology 65-TS-13-22Recalls & reported problems

Pioneer Surgical Technology, Inc. · Fortilink-TS Interbody Fusion Device (IBF) System with TETRAfuse 3D Technology, 13mm (H), 22mm (L) · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00846468084097), received between Aug 27, 2020 and Aug 27, 2020 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Pain1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 27, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED TO RTI SURGICAL ON (B)(6) 2020 THAT DURING A CLINICAL STUDY OF THE FORTILINK-TS SYSTEM IT WAS DISCOVERED THAT A REVISION SURGERY HAD TAKEN PLACE DUE TO PATIENT PAIN, NON-UNION, AND NON-FUSION. THE INDEX SURGERY WAS PERFORMED ON (B)(6) 2019 FOR INCREASING RIGHT L5-S1 FORAMINAL STENOSIS. FOLLOWING SURGERY, THE PATIENT CONTINUED TO EXPERIENCE BACK PAIN. REVISION WAS THEN PERFORMED ON (B)(6) 2020.

    Patient problems: Pain

    MAUDE report 10459757 ↗

Other Intervertebral fusion device with bone graft, lumbar devices

All Intervertebral fusion device with bone graft, lumbar devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page